No Data
No Data
Cingulate to Participate in Benzinga All Live Access Event
Cingulate to Attend DCAT Week 2024 in New York City
KANSAS CITY, Kan., March 06, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release (PTR) drug delivery platform technology
Cingulate Inc Bolsters Board, Targets Nasdaq Compliance
Cingulate Expands Board With New Directors Amid Financial Activity Surge
Press Release: Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to Its Board of Directors
Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors Announcement Follows Recent Public Offering and Successful Capital Raising Activity KANSAS CITY, Kan., Feb. 1
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersThermoGenesis Holdings (NASDAQ:THMO) stock moved upwards by 39.0% to $0.86 during Wednesday's regular session. The market value of their outstanding shares is at $2.7 million. Femasys (NASDAQ:F
No Data